An invited narrative review on artificial intelligence in pediatric nephrology. Done as a tribute to the amazing pediatric nephrologists that I have been fortunate enough to meet and learn so much from over the course of my professional life. https://t.co/5E8zyIKEJi
RCTs are fundamental but advancing RCTs working together is what it’s really all about. Thanks KRA for the opportunity to discuss this with you today at 1400 hours. My privilege. @ISNkidneycare#ThisIsISN
Getting ready for Day2 of the ISN Scientific Writing Course, rewarded by the kindness and generosity of people, the enthusiasm and talent of participants and the amazing beauty of Kenya. @ISNKidneycare#ThisIsISN
The ISN Scientific Writing Course is starting today in Moumbasa, Kenya jointly with the Kenya Renal Association Conference (KRACON). Looking forward. Stay tuned #ISN
And the @ISNkidneycare Scientific Writing Course co-hosted by @TwSocNephrolTSN has come to an end❗Congratulations to all the participants 🎓🎉 Keep up the great work and aim for the stars 🚀✨ You got this 💪🏼
A huge thank you to our wonderful faculty and hosts 💐🙏🏼
#ThisIsISN
High-volume hemodiafiltration (HDF) continues to show superior outcomes compared to traditional hemodialysis (HD) for patients with end-stage kidney disease. The CONVINCE study found that high-volume HDF significantly reduces all-cause mortality, particularly infection-related deaths, and improves patient-reported outcomes. These findings suggest that HDF can offer a survival advantage over and above conventional HD, reinforcing its growing role in dialysis treatment.
In the latest episode of GMO Dialogues, Dr. @gstrip3, Professor of Nephrology at the University of Bari and Adjunct Professor of Epidemiology at University of Sydney, discusses the pivotal findings of the CONVINCE study, sharing valuable insights into how these findings may influence future dialysis practices for patients with end-stage kidney disease.
Watch the latest episode now and dive into the benefits of HDF: https://t.co/DW5rbcfgQs
#GMODialogues #CONVINCEStudy #MedicalResearch #Dialisys
🌐📚 Don’t miss Prof. @cellotonelli from Canada at ESNT Congress 2024, sharing valuable insights on the latest updates in CKD. Join the journey of knowledge with a renowned expert. #ESNT#CKD#ExpertInsights
📚👨🏫 Don’t miss Prof. @gstrip3 from Italy as he shares the latest results of hard endpoint trials in CKD. Learn how to shape the future of chronic kidney disease management. #CKD#nephrology
Waking up & reviewing a manuscript is a daily constitutional for me but… todays it is in Egypt for the scientific writing course/SWC @ISNkidneycare@ESNT_Egy
Kicking off the first ISN Scientific Writing Course in Africa in beautiful Cairo! Thank you @ESTN_Egy for the warm welcome! Promising and productive days ahead with 15 participants from all over Africa @ISNkidneycare
We are delighted to partner with @ESNT_Egy to deliver the first Scientific Writing Course in Africa and Middle East, taking place in Cairo, kicking off today!
Welcome to our 15 participants from all over Africa 👋